BILL Holdings holder plans $1.67M stock sale

BILL Holdings, Inc. (BILL) received a Rule 144 notice that Makahakama Foundation plans to sell up to 35,000 shares of its common stock through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

BILL Holdings, Inc. (BILL) received a Rule 144 notice that Makahakama Foundation plans to sell up to 35,000 shares of its common stock through Morgan Stanley Smith Barney LLC. The planned sale has an aggregate market value of $1,666,700 and is listed for September 2, 2026 on the NYSE. BILL Holdings had 85,276,782 shares outstanding, providing context for the size of this potential sale.

Key Figures

Shares to be sold: 35,000 shares Aggregate market value: $1,666,700 Shares outstanding: 85,276,782 shares +2 more

5 metrics

Shares to be sold 35,000 shares Common stock to be sold for Makahakama Foundation under Rule 144

Aggregate market value $1,666,700 Total market value of 35,000 BILL common shares covered by the notice

Shares outstanding 85,276,782 shares BILL Holdings common shares outstanding, provided as context in the notice

Planned sale date September 2, 2026 Anticipated date of sale on the NYSE

Security type Common stock Class of BILL Holdings securities to be sold

Key Terms

Rule 144, Founders Shares, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founders Shares financial

"Common | 04/21/2006 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

aggregate market value financial

"Common ... | 35000 | 1666700.00 | 85276782 | 09/02/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for BILL?

The notice states that Makahakama Foundation plans to sell up to 35,000 shares of BILL Holdings, Inc. common stock under Rule 144, through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,666,700 and a planned sale date of September 2, 2026.

How many BILL (BILL) shares are covered by this Rule 144 filing?

The filing covers up to 35,000 shares of BILL Holdings, Inc. common stock to be sold for the account of Makahakama Foundation, described as “Founders Shares.”

What is the aggregate market value of the BILL shares to be sold?

The aggregate market value of the BILL Holdings, Inc. shares covered by the notice is $1,666,700, corresponding to the planned sale of 35,000 common shares under Rule 144.

Who is executing the planned BILL share sale under Form 144?

The planned sale of BILL Holdings, Inc. common stock is indicated to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York.

When is the planned sale date for the BILL (BILL) shares in this Form 144?

The planned sale date disclosed is September 2, 2026, with trading to occur on the NYSE, subject to the usual conditions that apply to Rule 144 sales.

How many BILL Holdings shares are outstanding in relation to this Form 144 sale?

BILL Holdings, Inc. reports 85,276,782 shares outstanding of common stock, which provides context for the 35,000-share sale proposed by Makahakama Foundation in this Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 04:29 PM EDT Accepted by SEC EDGAR 09/02/2026 - 04:28 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001795497
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BILL HOLDINGS INC
SEC File Number	001-39149
Address of Issuer	6220 America Center Drive, Suite 100 San Jose CALIFORNIA 95002
Phone	6506217700
Name of Person for Whose Account the Securities are To Be Sold	MAKAHAKAMA FOUNDATION
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	35000	1666700.00	85276782	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/21/2006	Founders Shares	Issuer			35000	04/21/2006	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Rene Lacerte
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)